Immunotherapy Combinations for Lung Cancers: Challenges and Opportunities of Rapidly Evolving Treatments

AACR Lung IO Combo Program Image
Download All
Few oncology treatment paradigms are evolving as rapidly as those for lung cancer. In particular, emerging data and indications for immunotherapy combinations in both NSCLC and SCLC have resulted in an explosion of new therapeutic options. Review the program Webcast and download the slidesets to deepen your understanding of current and evolving best practices! This is not an official program of the American Association for Cancer Research Annual Meeting.
H. Jack West, MD
Program Director
Hossein Borghaei, MS, DO
Stephen V. Liu, MD

On-Demand Video Webcast

Watch this CME-certified on-demand Webcast from the CCO AACR satellite symposium, featuring expert faculty H. Jack West, MD; Hossein Borghaei, MS, DO; and Stephen V. Liu, MD, as they present the latest clinical advances in immunotherapy combinations for lung cancers.

H. Jack West, MD
Program Director
Hossein Borghaei, MS, DO Stephen V. Liu, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: June 25, 2019 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue